RECOMBINANT ALPHA-1 ANTITRYPSIN AS A NOVEL THERAPY FOR PANDEMIC INFLUENZA

$293,599FY2022Defense Health AgencyDOD

Monash University, Victoria

Investigators

View source on USAspending →